PHARMAPLAN returns: TTP AG buys European engineering companies from NNE A/S

Frankfurt am Main / Copenhagen (ots) - TTP AG, Frankfurt/Main and
it's subsidiary TTP GmbH, has signed an agreement with the Danish NNE
A/S in Copenhagen for the purchase of three NNE subsidiaries based in
Switzerland, Germany and Belgium.

TTP AG is an operational holding company specialising in
production-related engineering services for the process industry. It
is the majority shareholder of TRIPLAN Aktiengesellschaft, based in
Bad Soden am Taunus, an engineering service company with focus on the
life science, chemical and petrochemical sectors.

NNE specialises in engineering and consulting services,
particularly for major projects in the growth markets of
biotechnology and pharmaceuticals, and covers all areas of EPCM
(Engineering, Procurement, Construction Management) projects.

TTP AG plans to continue managing the three NNE subsidiaries in
the European market as a largely independent company in the
pharmaceutical and life science sector, and to revive the PHARMAPLAN
brand name, under which the companies were known until 2017.

Joachim Grendel, the CEO of TTP AG: "TRIPLAN's local presence,
competencies, business areas and value chains and those of the future
PHARMAPLAN complement each other perfectly. This leads to a
sustainably better market and competitive position thanks to growth
synergies in Europe - even in the face of deteriorating economic
conditions and market environments. Together we comprise one of the
leading medium-sized engineering companies for the process industry
in Europe."

Dr. Andreas Bonhoff, CFO of TRIPLAN AG: "The names TRIPLAN and
PHARMAPLAN stand for excellent engineering culture, which we want to
preserve respectfully together with our employees and further develop
in a quality-oriented manner. PHARMAPLAN and TRIPLAN are to present
themselves confidently as European companies, seize new market
opportunities and at the same time act as attractive employers in the
top league."

Jesper Kløve, the CEO of NNE A/S: "The transaction is a great
strategic match for both parties, where NNE A/S strategy is to
intensify the geographical focus on the markets and customers of
Denmark, the US and India. I strongly believe that TTP AG will create
a bright future for our colleagues in Switzerland, Germany and
Belgium, by further developing the strong local presence in the
markets"

The acquisition is expected to take effect at the end of March
2019. The parties have agreed not to disclose the purchase price. The
NNE companies in Germany, Switzerland and Belgium have around 360
employees and generated sales of EUR 61 million in 2018. Triplan AG
is active in Germany, Switzerland and India, and have 420 employees,
with a consolidated annual turnover of EUR 47 million in 2018.

About TTP AG

TTP AG in Frankfurt am Main specialises in production-related
engineering services for the process industry. It is the majority
shareholder of TRIPLAN Aktiengesellschaft, based in Bad Soden am
Taunus, an engineering service company with a focus on the life
science, chemical and petrochemical sectors.

About TRIPLAN Aktiengesellschaft

TRIPLAN Aktiengesellschaft and its affiliated companies ("TRIPLAN"
or the "TRIPLAN Group") provide engineering services for plant
construction in the chemical, pharmaceutical, petrochemical and
biochemical industries. The range of services includes technical
consulting, plant planning in close alignment with operations, as
well as the overall planning of process plants and the planning of
new and existing laboratory, pilot, production, infrastructure and
supply plants. As anindependent and neutral general and component
planner, TRIPLAN undertakes the technical development for new
construction projects, conversion projects and the modernisation and
optimisation of industrial plants. It has a renowned and long-term
customer base of companies in the regional environments of its
branches. Multi-year framework agreements have been concluded with
many of these customers.

About NNE A/S

NNE A/S (NNE) is a leading international company, specialised in
pharma engineering. NNE helps pharmaceutical companies bring products
to market and solve our customers' most complex manufacturing
challenges within: Biotech / API, Oral solid dosage, Fill and finish
- and Assembly and pack. NNE delivers expert pharma engineering
throughout the entire manufacturing and project lifecycle, from
front-end studies, design, project execution to optimisation of
running operations. The focus expertise areas are within
pharma-process, pharma-facilities and pharmaautomation, all within a
GMP-regulated environment. NNE is a recognised contributor to many of
the organisations that set standards in pharmaceutical quality,
manufacturing/engineering and guidelines. NNE has a strong customer
base developed over many years, with high degree repeatable business
year after year.

Contact:
B.L.B.R
Burkhard Leschke
Brand Relations GmbH
Eigelstein 103 -113
50668 Köln
Phone +49 221 / 27190656
Mobile +49 16093803331
b.leschke@blbr.de

Original-Content von: TTP AG / TRIPLAN AG / NNE A/S, übermittelt durch news aktuell